Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/25/2014US8680129 Compounds, composition, methods, targets for cancer therapy
03/25/2014US8680128 Synergistic antimicrobial composition of 1,2-benzisothiazolin-3-one and tris(hydroxymethyl)nitromethane
03/25/2014US8680126 Fluorinated thiazoles for use in treating cancer
03/25/2014US8680125 Fullerene therapies for inflammation
03/25/2014US8680124 Treatment of cancers with acquired resistance to kit inhibitors
03/25/2014US8680123 Substituted N-aryl pyridinones
03/25/2014US8680122 Substituted pyrrolones as allosteric modulators of glucokinase
03/25/2014US8680120 Indole derivative or pharmaceutically acceptable salt thereof
03/25/2014US8680118 Therapeutic agents useful for treating pain
03/25/2014US8680117 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
03/25/2014US8680116 Quinolinone PDE2 inhibitors
03/25/2014US8680115 Tetrahydroquinoline analogues as muscarinic agonists
03/25/2014US8680114 AKT protein kinase inhibitors
03/25/2014US8680113 BMI-1 protein expression modulators
03/25/2014US8680112 Methods for treating diseases with 4-hydroxybenzomorphans
03/25/2014US8680111 Macrocyclic derivatives for the treatment of diseases
03/25/2014US8680110 P2X4 receptor antagonist
03/25/2014US8680109 Combination product comprising SRC kinase inhibitor AZDO530 and an antioestrogen or EGFR-TK-inhibitor
03/25/2014US8680108 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
03/25/2014US8680107 Activators and therapeutic applications thereof
03/25/2014US8680106 Methods for treating HCV
03/25/2014US8680105 Method of treating down's syndrome
03/25/2014US8680104 Piperazinylpiperidine derivatives as chemokine receptor antagonists
03/25/2014US8680103 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
03/25/2014US8680102 Pyrrole derivatives, their preparation and their therapeutic application
03/25/2014US8680101 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use
03/25/2014US8680100 Sulfonylhydrazide compounds for treating proliferative disorders
03/25/2014US8680099 6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders
03/25/2014US8680098 Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
03/25/2014US8680097 Benzothiophene alkanol piperazine derivatives and their use as antidepressant
03/25/2014US8680096 Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
03/25/2014US8680095 Heterocycle compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the APP metabolism occurs
03/25/2014US8680094 1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
03/25/2014US8680093 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
03/25/2014US8680092 Nitrogenous heterocyclic compound and medicinal use thereof
03/25/2014US8680091 6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
03/25/2014US8680090 Sulfonyl containing benzothiazole inhibitors of endothelial lipase
03/25/2014US8680089 Fused pyridine derivatives
03/25/2014US8680088 Methods for chronic pain management and treatment using HCG
03/25/2014US8680087 Macrocyclic amides, pharmaceutical compositions, preparation methods and uses thereof
03/25/2014US8680086 Methods for chronic pain management and treatment using HCG
03/25/2014US8680085 Composition and method for treatment of diabetes
03/25/2014US8680084 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
03/25/2014US8680083 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
03/25/2014US8680082 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
03/25/2014US8680081 Prophylactic treatment of migraine
03/25/2014US8680080 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
03/25/2014US8680078 Stable ophthalmic formulations
03/25/2014US8680077 Prochelators useful for inhibiting metal-associated toxicity
03/25/2014US8680076 Methods of treatment, improvement and prevention using haloaryl substituted aminopurines
03/25/2014US8680075 Methods and compositions for inhibiting cellular proliferation and surgical adhesion
03/25/2014US8680074 Use of chitosans to increase nail growth rate
03/25/2014US8680073 Stable hyaluronan/steroid formulation
03/25/2014US8680072 Use of alginate oligomers in combating biofilms
03/25/2014US8680070 Medical implants containing adenosine receptor agonists and methods for inhibitiing medical implant loosening
03/25/2014US8680068 Herpes virus strains
03/25/2014US8680061 Medicinal forms of phospholipid preparations and methods for their preparation
03/25/2014US8680048 Methods for treating HCV
03/25/2014US8680043 Synthetic immunogenic glycoconjugate for melanoma immunotherapy
03/25/2014US8680042 Methods of treating sickle cell anemia-related conditions with MK-801 or memantine
03/25/2014US8680041 Genetic variations associated with tumors
03/25/2014US8679736 Removal of adenine during a pathogen reduction process in whole blood or red blood cells by dilution
03/25/2014US8679549 Electrolyte purgative
03/25/2014US8679546 Ruminant feed pellet composition with controlled release of physiologically active substances, and procedure for preparation and use thereof
03/25/2014US8679545 Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
03/25/2014US8679544 Formulation of diclofenac
03/25/2014US8679540 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
03/25/2014US8679535 Sustained release matrix systems for highly soluble drugs
03/25/2014US8679534 HMG-CoA reductase inhibitor extended release formulation
03/25/2014US8679533 Pramipexole once-daily dosage form
03/25/2014US8679532 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
03/25/2014US8679527 Antimicrobial compositions
03/25/2014US8679516 High alcohol content foaming compositions with silicone-based surfactants
03/25/2014US8679506 Glucan-based vaccines
03/25/2014US8679503 Methods, compositions and kits relating to chitnases and chitnase-like molecules and inflammation disease
03/25/2014US8679499 Methods for relieving asthma-associated airway hyperresponsiveness
03/25/2014US8679470 Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
03/25/2014US8679462 Methods of preventing respiratory infections
03/25/2014US8679453 Contrast agents
03/25/2014CA2789114C Medical compositions for intravesical treatment of bladder cancer
03/25/2014CA2779723C Oral drug delivery system
03/25/2014CA2753899C Polyalkylene glycol with moiety for conjugating biologically active compounds
03/25/2014CA2744056C Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
03/25/2014CA2735177C Saturated bicyclic heterocyclic derivatives as smo antagonists
03/25/2014CA2733780C Gentle, non-irritating, non-alcoholic skin disinfectant
03/25/2014CA2706369C Antibacterial aminoglycoside analogs
03/25/2014CA2699989C N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor
03/25/2014CA2690357C Bifunctional synthetic molecules
03/25/2014CA2665428C Hdac inhibitors
03/25/2014CA2656003C Fused cyclic compounds
03/25/2014CA2652633C Crystalline forms of gemcitabine amide prodrug, compositions and use thereof
03/25/2014CA2651596C Percutaneous absorption preparations of antidementia drugs
03/25/2014CA2630617C Compositions and methods for modulating gated ion channels
03/25/2014CA2623879C Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
03/25/2014CA2621988C Quinoline derivatives and use as antitumor agents
03/25/2014CA2621359C Polysaccharide produced by microorganism belonging to genus bifidobacterium
03/25/2014CA2620915C Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
03/25/2014CA2620688C Heterocyclic compound
03/25/2014CA2618741C Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
03/25/2014CA2618212C Combination of a long-acting hypnotic agent and a short-acting hypnotic agent and therapeutic use of same
1 ... 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 ... 7860